Heart effects of a natural protein in obesity and high blood pressure
Treatments studied
Part of Heart & circulation, Hormones & metabolism clinical trials.
This study tests whether a natural protein called angiotensin-(1-7) can improve heart health in people with obesity and high blood pressure. It may help researchers find new ways to treat these conditions together.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your age must be between 18 and 65.
- Your body mass index (BMI) must be between 30 and 45.
- You must have high blood pressure (above 130/80) or take medication for it.
- You cannot have serious heart or blood vessel disease, diabetes, or be a current smoker.
- You cannot take more than two blood pressure medications or certain other drugs (like antidepressants, blood thinners, or steroids).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests how a medication that affects the body’s angiotensin system (angiotensin-(1-7)) changes metabolism in adults with obesity, insulin resistance, and high blood pressure. It may help researchers understand whether this approach can improve blood sugar/insulin function and related body changes.
This early-phase study looks at how the body’s “fight-or-flight” signals may be involved in weight gain (obesity) and high blood pressure. It may help researchers understand the biology and guide future treatments.
This early-stage study tests a new way to help control high blood pressure that is linked to obesity. It may help people whose blood pressure is high based on a 24-hour blood pressure monitor.
This trial looks at how a natural hormone called aldosterone (which helps control blood pressure) and a treatment that silences it affect people with high blood pressure. It aims to find better ways to manage high blood pressure by studying real patient data.
This study looks at how mineralocorticoid-related hormone signaling affects small heart blood vessels and how efficiently the heart works in people with high blood pressure. It may help doctors understand which treatments could improve heart function in hypertension.
This study tests whether a supervised exercise program can improve heart health and a protein called sestrin-2 in women who have both high blood pressure and obesity. If you're eligible, you'll get structured exercise sessions and health monitoring.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.